Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    274
  • comment
    1
  • views
    304

Presently, there are over 20 screening platforms enabling therapy development efforts ‘Synthetic Lethality-based Drug’


Damon Salvatore

4 views

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

 

To order this 485+ page report, which features 195+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html

 

The USD 8 billion (by 2030) financial opportunity within the synthetic lethality-based drugs and targets market has been analyzed across the following segments:

§  Type of molecule

§  Small Molecule

§  Biologic

 

§  Target disease indication

§  Breast Cancer

§  Colorectal Cancer

§  Fallopian Tube Cancer

§  Gastric Cancer

§  Head and Neck Cancer

§  Lung Cancer

§  Ovarian Cancer

§  Peritoneal Cancer

§  Others

 

§  Type of synlet target

§  APE1 / Ref-1

§  Chk1

§  GLS1

§  PARP

§  Pol θ

§  PP2A

§  Wee1

 

§  Route of administration 

§  Oral

§  Intravenous

 

§  Key geographical regions

§  North America

§  Europe

§  Asia Pacific

  • Rest of the World

 

The Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”.report features the following companies, which we identified to be key players in this domain:

§  AbbVie

§  AstraZeneca

§  AtlasMedx

§  BeiGene

§  Chordia Therapeutics

§  Clovis Oncology

§  GlaxoSmithKline

§  IDEAYA Biosciences

§  Mission Therapeutics

§  Pfizer

§  Repare Therapeutics

§  Sierra Oncology

§  SyntheX Labs

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction to DNA Damage and Repair Systems
 

4. Introduction to Synthetic Lethality
 

5. Market Overview
 

6. Company Profiles
 

7. Emerging Trends on Social Media 
 

8. Publication Analysis
 

9. Abstract Analysis
 

10. Academic Grants Analysis
 

11. Funding and Investment Analysis
 

12. Target Benchmark Analysis

 

13. Role of Companion Diagnostics in Synthetic Lethality

 

14. Market Forecast
 

15. Concluding Remarks
 

16. Executive Insights

 

17. Appendix 1: Tabulated Data

 

18. Appendix 2: List of Companies and Organizations

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

0 Comments


Recommended Comments

There are no comments to display.

Guest
Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
  • Create New...